Targeting IBC: Antibody-Drug Conjugates | 2026 Inflammatory Breast Cancer Program Patient Forum
🛍️ Products Mentioned (1)
Paolo Tarantino, MD, research fellow at Dana-Farber Cancer Institute discusses antibody-drug conjugates (ADCs) for inflammatory breast cancer (IBC) at the IBC Program Patient Forum in April 2026. For more information about the IBC Program, visit https://www.dana-farber.org/inflammatory-breast-cancer-program
🎬 More from Dana-Farber Cancer Institute
Understanding Chemo Neuropathy: A Webinar by the Older Adults with GI Cancer Program | Dana-Farber
19 views
Learning About Chronic Lymphocytic Leukemia | Lymph Notes: A Lymphoma Learning Series
112 views
ASCO26: David Reardon, MD Glioblastoma Vaccine | Dana-Farber Cancer Institute
106 views
Society of Gynaecological Oncology Congress 2026: Tara Berman, MD | Dana-Farber Cancer Institute
30 views
ASCO26: Julia Rotow, MD Silevertinib in Lung Cancer | Dana-Farber Cancer Institute
55 views
ASCO26: Atish Choudhury, MD, PhD A-DREAM/Alliance A032101 | Dana-Farber Cancer Institute
38 views